Viewing Study NCT01626859


Ignite Creation Date: 2025-12-24 @ 2:29 PM
Ignite Modification Date: 2026-01-01 @ 8:08 PM
Study NCT ID: NCT01626859
Status: COMPLETED
Last Update Posted: 2021-04-12
First Post: 2012-06-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia
Sponsor: Tanabe Pharma Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Schizophrenia View
None Antipsychotic Agents View
None Mental Disorder View
None Psychotropic Drugs View
None Dopamine Agents View
None Central Nervous System Agents View